AstraZeneca plans to file for US emergency use authorization next month for its COVID-19 vaccine — but the process could be under intense scrutiny with several European countries pausing its use over concerns about blood clots.

AstraZeneca plans to file for US emergency use authorization next month for its COVID-19 vaccine — but the process could be under intense scrutiny with several European countries pausing its use over concerns about blood clots.